USPSTF Recommends Against Routine Screening for Carotid Artery Stenosis
Risks Outweigh Benefits in General Population
By News Staff
2/5/2008
The reliability of the most feasible screening test for severe CAS -- carotid duplex ultrasonography -- has not been established; such testing often yields false-positive results. Positive results are most often confirmed by digital subtraction angiography, which itself can cause strokes in certain patients. Other confirmatory tests, such as magnetic resonance angiography, may be inaccurate. Thus, some individuals with false-positive results will receive unnecessary invasive carotid endarterectomy surgery.
In addition, despite good evidence showing that carotid endarterectomy among selected high-risk clinical trial participants with asymptomatic severe CAS can reduce the five-year absolute incidence of all strokes or perioperative deaths by about 5 percent, the projected benefits among the general primary care population were judged to be "no greater than small," said the task force.
Risk factors for CAS include older age, male gender, hypertension, smoking, hypercholesterolemia and heart disease. Instead of screening for CAS in the general adult population, the USPSTF recommends that physicians screen their patients for hypertension, hyperlipidemia and smoking. For patients who are at increased risk of heart disease, physicians should discuss aspirin chemoprevention.
It's worth noting that this USPSTF recommendation applies only to adult patients who have no neurological signs or symptoms, including a history of transient ischemic attacks, or TIAs, or stroke. Eligible patients who have a carotid TIA should be evaluated immediately for consideration of carotid endarterectomy.
One Dose of H1N1 Vaccine Immunogenic in High Percentage of Pregnant Women
FDA Revises Diabetes Drug Prescribing Information
H1N1 Vaccine Availability Increasing Slowly
ACIP Supports 'Permissive Use' of Gardasil in Males
CDC Survey Shows Overall Gains in Teens' Immunization Rates
FDA Approves Gardasil for Males, Bivalent HPV Vaccine for Girls, Women
New USP Standards for Heparin Decrease Unit Dose Potency
H1N1 Vaccine Deliveries Begin This Week
Clinical Trial of H1N1 in Kids, Teens Shows Mixed Results
Federal Health Officials Push H1N1 Vaccine for Adults, Health Workers
IOM: N95 Respirators Offer H1N1 Flu Defense for Health Personnel
CDC, FDA Study Reinforces Safety, Efficacy of Gardasil
H1N1 Vaccine Clinical Trials in Adults Free of Adverse Events
H1N1 Vaccine Production Lagging Behind Expectations








